Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom.

Drugmaker Merck said Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with President Trump’s tariffs. The new facility will produce ...

Seven weeks after opening a new $1 billion vaccine manufacturing facility in North Carolina, Merck has revealed that it is breaking ground on another $1 billion plant—this one in Wilmington ...

Here’s what to know. In February, Merck officials presented to Delaware’s Council of Development Finance to make their case for receiving a grant to invest in their ambitious project.

Delaware. In a FOX Business exclusive, company CEO Robert Davis told "Mornings with Maria" the effort will take time as Merck builds the capability, but the payoff could mean stable access to ...

April 29 (Reuters) - U.S. drugmaker Merck (MRK.N), opens new tab said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it prepares to deal with ...

Merck is constructing a $1 billion drug manufacturing facility in Wilmington, Delaware, as part of its commitment to investment and growth in the United States. The company on Tuesday said it ...

First, it was Panasonic. Now, another major company is planting deeper roots in De Soto. Merck Animal Health has announced an expansion of its De Soto operations, and it’s bringing hundreds of ...